Literature DB >> 19490182

Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy.

E T Overton1, D Nurutdinova, J Freeman, W Seyfried, K E Mondy.   

Abstract

BACKGROUND: Kidney disease remains a prevalent problem in HIV care. The contribution of highly active antiretroviral therapy (HAART), HIV disease factors and traditional factors needs further evaluation.
METHODS: A cross-sectional study of all patients seen at an HIV outpatient clinic during 2005 was performed. All data were collected from medical record review. Multivariate regression modelling was used to identify independent predictors of lower glomerular filtration rate (eGFR) and chronic renal failure (CRF) from factors significant in univariate analysis. eGFR was calculated using the simplified modification of diet in renal disease equation. Results were compared with those for persons from the National Health and Nutrition Examination Survey (NHANES) matched for age, race and gender.
RESULTS: Of 845 HIV-infected persons, 64% were men and 34% were Caucasian, and the mean age was 39.8 years. Thirty per cent of the patients had proteinuria and 43% had eGFR<90 mL/min/1.73 m2. Persons on HAART (63%) had a lower mean eGFR than those not on HAART (92.0 vs. 101.6). In multivariate analyses, significant predictors of eGFR decline were diagnoses of hypertension, hyperlipidaemia, proteinuria, use of tenofovir or stavudine, and lower viral load. Compared with those in NHANES, HIV-infected persons had a lower mean eGFR (94.9 vs. 104.2) and a higher prevalence of CRF (8% vs. 2%).
CONCLUSION: In this cohort, the prevalence of CRF is low, but remains higher than that of the general population. Clinicians should routinely screen for early asymptomatic kidney disease to address risk factors that can be treated.

Entities:  

Mesh:

Year:  2009        PMID: 19490182      PMCID: PMC3918930          DOI: 10.1111/j.1468-1293.2009.00693.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  27 in total

1.  Molecular mechanisms of lipid disorders in nephrotic syndrome.

Authors:  Nosratola D Vaziri
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

2.  Fanconi syndrome and renal failure induced by tenofovir: a first case report.

Authors:  David Verhelst; Matthieu Monge; Jean-Luc Meynard; Bruno Fouqueray; Béatrice Mougenot; Pierre-Marie Girard; Pierre Ronco; Jerome Rossert
Journal:  Am J Kidney Dis       Date:  2002-12       Impact factor: 8.860

3.  Assessing kidney function--measured and estimated glomerular filtration rate.

Authors:  Lesley A Stevens; Josef Coresh; Tom Greene; Andrew S Levey
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

Review 4.  Cardiovascular risks of antiretroviral therapies.

Authors:  Kristin Mondy; Pablo Tebas
Journal:  Annu Rev Med       Date:  2007       Impact factor: 13.739

5.  Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study.

Authors:  P Muntner; J Coresh; J C Smith; J Eckfeldt; M J Klag
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

6.  Mechanism of active renal tubular efflux of tenofovir.

Authors:  Adrian S Ray; Tomas Cihlar; Kelly L Robinson; Leah Tong; Jennifer E Vela; Michael D Fuller; Lani M Wieman; Eugene J Eisenberg; Gerry R Rhodes
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

7.  Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome.

Authors:  Carmine Gazzaruso; Raffaele Bruno; Adriana Garzaniti; Stefano Giordanetti; Pietro Fratino; Paolo Sacchi; Gaetano Filice
Journal:  J Hypertens       Date:  2003-07       Impact factor: 4.844

8.  Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir.

Authors:  Heidi M Crane; Bryan Kestenbaum; Robert D Harrington; Mari M Kitahata
Journal:  AIDS       Date:  2007-07-11       Impact factor: 4.177

9.  Chronic renal failure among HIV-1-infected patients.

Authors:  Amanda Mocroft; Ole Kirk; Jose Gatell; Peter Reiss; Panagiotis Gargalianos; Kai Zilmer; Marek Beniowski; Jean-Paul Viard; Schlomo Staszewski; Jens D Lundgren
Journal:  AIDS       Date:  2007-05-31       Impact factor: 4.177

10.  CD4+ count-guided interruption of antiretroviral treatment.

Authors:  W M El-Sadr; J D Lundgren; J D Neaton; F Gordin; D Abrams; R C Arduino; A Babiker; W Burman; N Clumeck; C J Cohen; D Cohn; D Cooper; J Darbyshire; S Emery; G Fätkenheuer; B Gazzard; B Grund; J Hoy; K Klingman; M Losso; N Markowitz; J Neuhaus; A Phillips; C Rappoport
Journal:  N Engl J Med       Date:  2006-11-30       Impact factor: 91.245

View more
  28 in total

Review 1.  Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection.

Authors:  Denise C Hsu; Irini Sereti
Journal:  Drugs       Date:  2016-04       Impact factor: 9.546

Review 2.  Tenofovir-induced nephrotoxicity: incidence, mechanism, risk factors, prognosis and proposed agents for prevention.

Authors:  Atefeh Jafari; Hossein Khalili; Simin Dashti-Khavidaki
Journal:  Eur J Clin Pharmacol       Date:  2014-06-25       Impact factor: 2.953

Review 3.  Risk of coronary heart disease in patients with HIV infection.

Authors:  Markella V Zanni; Judith Schouten; Steven K Grinspoon; Peter Reiss
Journal:  Nat Rev Cardiol       Date:  2014-10-21       Impact factor: 32.419

4.  Greater Weight Gain in Treatment-naive Persons Starting Dolutegravir-based Antiretroviral Therapy.

Authors:  Kassem Bourgi; Peter F Rebeiro; Megan Turner; Jessica L Castilho; Todd Hulgan; Stephen P Raffanti; John R Koethe; Timothy R Sterling
Journal:  Clin Infect Dis       Date:  2020-03-17       Impact factor: 9.079

Review 5.  Renal dysfunction in the setting of HIV/AIDS.

Authors:  Jose M Miro; Federico Cofan; Joan C Trullas; Christian Manzardo; Carlos Cervera; Montserrat Tuset; Federico Oppenheimer; Mercedes Brunet; Asuncion Moreno; Josep M Campistol; Jose M Gatell
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

6.  Mild renal impairment is associated with calcified plaque parameters assessed by computed tomography angiography in people living with HIV.

Authors:  Lediya T Cheru; Kathleen V Fitch; Charles F Saylor; Michael Lu; Udo Hoffmann; Janet Lo; Steven K Grinspoon
Journal:  AIDS       Date:  2019-02-01       Impact factor: 4.177

7.  Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.

Authors:  Lene Ryom; Amanda Mocroft; Ole Kirk; Signe W Worm; David A Kamara; Peter Reiss; Michael Ross; Christoph A Fux; Philippe Morlat; Olivier Moranne; Colette Smith; Jens D Lundgren
Journal:  J Infect Dis       Date:  2013-02-04       Impact factor: 5.226

Review 8.  Screening for chronic kidney disease in HIV-infected patients.

Authors:  Michelle M Estrella; Derek M Fine
Journal:  Adv Chronic Kidney Dis       Date:  2010-01       Impact factor: 3.620

9.  Prevalence of renal disease within an urban HIV-infected cohort in northern Italy.

Authors:  Leonardo Calza; Elisa Vanino; Eleonora Magistrelli; Caterina Salvadori; Alessandra Cascavilla; Vincenzo Colangeli; Maria Assunta Di Bari; Roberto Manfredi; Pierluigi Viale
Journal:  Clin Exp Nephrol       Date:  2013-05-28       Impact factor: 2.801

10.  Hematologic, hepatic, renal, and lipid laboratory monitoring after initiation of combination antiretroviral therapy in the United States, 2000-2010.

Authors:  Elizabeth L Yanik; Sonia Napravnik; Patrick Ryscavage; Joseph J Eron; Susan L Koletar; Richard D Moore; Anne Zinski; Stephen R Cole; Peter Hunt; Heidi M Crane; James Kahn; William C Mathews; Kenneth H Mayer; Babafemi O Taiwo
Journal:  J Acquir Immune Defic Syndr       Date:  2013-06-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.